Stockreport

Dr Reddy's Laboratories Ltd (RDY) Q3 2026 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF EBITDA Margin: 23.5%, adjusted to 24.8% excluding a onetime provision. Gross Profit Margin: 53.6%, adjusted to 54.1% excluding a onetime provision. SG&A Spend: INR2 [Read more]